Clinton Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Clinton Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-16,754	Closed	-$248K	–	995
2017 Q1	$248K	Sell	16,754 -20,803	-55%	-$337K	0.01%	818
2016 Q4	$608K	Buy	+37,557	New	+$681K	0.04%	518
2016 Q3	–	Sell	-30,211	Closed	-$498K	–	1136
2016 Q2	$498K	Sell	30,211 -92,003	-75%	-$1.49M	0.02%	640
2016 Q1	$2.02M	Buy	122,214 +38,248	+46%	+$669K	0.12%	254
2015 Q4	$1.82M	Buy	83,966 +29,609	+54%	+$576K	0.15%	221
2015 Q3	$1.08M	Buy	+54,357	New	+$1.72M	0.1%	281

Other funds holding HZNP

Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return